Zenas BioPharma Cash Flow Statement (2023-2026) | ZBIO

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) 35.62M-32.86M-27.80M-37.98M-38.61M-52.17M-33.57M-52.22M-51.50M-251.13M-80.99M
Depreciation and Depletion (Quarter) 0.03M0.03M0.04M0.04M0.03M0.02M0.01M0.01M0.01M0.01M
Share-based Compensation (Quarter) 1.00M1.14M0.95M1.54M2.84M-4.23M5.39M6.04M81.20M7.58M80.30M
Cash from Operations (Quarter) -15.40M-19.10M-30.96M-31.06M-38.55M-37.05M-41.74M-41.12M-52.41M-75.20M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) -0.38M-0.94M-0.19M-0.42M-0.11M
Depreciation & Amortization (CF) (Quarter) 0.03M0.03M0.04M0.04M0.03M0.02M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Account Payables (Quarter) 3.12M3.41M-0.48M3.39M5.42M2.88M-12.09M-1.95M1.12M1.79M
Change in Accured Expenses (Quarter) 3.23M1.50M-0.97M9.67M11.87M-11.16M16.31M0.10M9.80M-4.96M
Other Working Capital Changes (Quarter) -1.36M-1.79M3.10M-1.79M8.18M0.35M-1.16M1.60M2.36M6.48M
Investing Activities
Capital Expenditures (Quarter) 0.02M0.04M0.07M0.02M0.00M
Change in Acquisitions & Divestments (Quarter) 12.86M14.26M104.24M69.53M108.13M
Cash from Investing Activities (Quarter) -0.02M-0.04M-26.76M-3.73M-86.27M-112.29M40.04M-93.36M31.61M
Financing Activities
Other financing activities (Quarter) 0.05M0.04M0.12M258.70M0.08M0.10M1.72M-1.54M0.37M
Cash from Financing Activities (Quarter) 0.05M-0.61M177.74M233.98M1.85M0.10M1.72M72.62M140.84M433.48M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 100.00M
Additional items
Exchange Rate Effect (Quarter) -0.09M0.04M0.03M-0.05M0.14M-0.05M-0.24M0.03M0.01M-0.31M
Change in Cash (Quarter) -15.45M-19.70M146.78M176.11M-40.30M-123.28M-152.55M71.56M-4.92M389.58M
Free Cash Flow (Quarter) -15.40M-19.12M-30.99M-31.06M-38.63M-37.07M-41.74M-41.12M-52.41M-75.20M
Net Cash Flow (Quarter) -15.35M-19.74M146.75M176.16M-40.44M-123.23M-152.31M71.53M-4.93M389.89M